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Abstract
Obligate intracellular Apicomplexa parasites share a unique invasion mechanism involving a tight interaction between the
host cell and the parasite surfaces called the moving junction (MJ). The MJ, which is the anchoring structure for the invasion
process, is formed by secretion of a macromolecular complex (RON2/4/5/8), derived from secretory organelles called
rhoptries, into the host cell membrane. AMA1, a protein secreted from micronemes and associated with the parasite surface
during invasion, has been shown in vitro to bind the MJ complex through a direct association with RON2. Here we show that
RON2 is inserted as an integral membrane protein in the host cell and, using several interaction assays with native or
recombinant proteins, we define the region that binds AMA1. Our studies were performed both in Toxoplasma gondii and
Plasmodium falciparum and although AMA1 and RON2 proteins have diverged between Apicomplexa species, we show an
intra-species conservation of their interaction. More importantly, invasion inhibition assays using recombinant proteins
demonstrate that the RON2-AMA1 interaction is crucial for both T. gondii and P. falciparum entry into their host cells. This
work provides the first evidence that AMA1 uses the rhoptry neck protein RON2 as a receptor to promote invasion by
Apicomplexa parasites.
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Introduction
Apicomplexa parasites are responsible for important diseases
affecting humans and animals, such as toxoplasmosis, malaria,
neosporosis, coccidiosis and cryptosporidiosis. The most detri-
mental infection is malaria, caused by a parasite from the genus
Plasmodium. It is transmitted by female Anopheles mosquito, placing
about 40 per cent of the world’s population at risk of high
morbidity and mortality. Most Apicomplexa are obligate intracel-
lular parasites. The cell invasion machinery of these parasites is
highly conserved and involves a structure called the moving
junction (MJ) formed between the parasite and host cell
membranes [1]. The MJ moves from the apex to the posterior
of the parasite, leading to its internalization into a new
compartment called the parasitophorous vacuole (PV). The
molecular components of the MJ have been recently deciphered
[2,3], showing that proteins unique to the Apicomplexa and
generally conserved within the phylum are secreted from secretory
organelles of the parasites called the rhoptries. Four rhoptry neck
proteins from Toxoplasma gondii (RON2, RON4, RON5 and
RON8) form a complex that is discharged during invasion [2,3,4]
and targeted to the host cell membrane [5]. This complex has
been found associated in vitro with the protein apical membrane
antigen 1 (AMA1) [2,6,7], which is contained in another set of
parasite secretory organelles called micronemes and discharged
prior to the secretion of rhoptries during invasion [8]. AMA1 was
first identified in P. knowlesi [9] and although its function was not
clearly understood, it was shown to relocalize from the
micronemes to the parasite surface and to be essential to parasite
survival in T. gondii and P. falciparum [10,11]. Numerous lines of
evidence suggest that this conserved protein plays a central role in
host cell invasion by Apicomplexa parasites; for instance,
antibodies against AMA1 block parasite invasion [7,12] and a
conditional T. gondii AMA1 null mutant is unable to invade host
cells [10]. During the past decade, AMA1 has become a major
candidate for antimalarial vaccine development (see [13] for a
review). In addition, the discovery of its association with the T.
gondii MJ complex in vitro [2] and the demonstration of a similar
complex in Plasmodium species [14,15,16] have reinforced interest
in AMA1 as a target for therapeutic development. AMA1 vaccine
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protective immune effector mechanism appears to be antibodies
that block invasion [17]. Mimotope approaches are also being
developed as therapeutic strategies. The recent resolution of x-ray
crystal structures of P. vivax [18], P. falciparum [19] and T. gondii
AMA1 [20] have revealed a conserved hydrophobic trough
surrounded by polymorphic loops that are the target of Plasmodium
growth-inhibitory antibodies [21,22].
In P. falciparum, two recent publications [14,23] showed that an
antibody directed against AMA1 or a short peptide (R1 peptide)
inhibited invasion by preventing PfAMA1 from interacting with
the PfRON complex, without defining which RON is involved in
this interaction. In Toxoplasma, we have shown that RON2
interacts directly with AMA1 in vitro and is exported with the
other RONs to the host cell membrane [5], with RON4/5/8
being exposed to the cytoplasmic face of the host cell membrane
and RON2 being predicted as a transmembrane (TM) protein.
Although we could not determine the topology of RON2 once
secreted and associated with the host cell membrane, we proposed
a model whereby the parasite secretes and inserts the interacting
components on both sides of the MJ, i.e. the plasma membranes of
the host (RON2) and the parasite (AMA1) [5], respectively. In this
model, RON4/5/8 anchor the junctional complex to the host cell
cytoskeleton and/or restrict the access of host cell membrane
proteins to the PVM.
Here we have further characterized the molecular interplay
between AMA1 and RON2 in T. gondii and P. falciparum by
identifying an interaction domain in RON2. We have also
demonstrated the functionality and role of the RON2-AMA1
interaction during the invasion step. Our results open perspectives
for new ways of interfering with parasite invasion, with a clear
therapeutic potential against Apicomplexa.
Results
TgRON2 localizes at the MJ during invasion
While anti-RON4, anti-RON5 and anti-RON8 antibodies
recognized the characteristic ring-shaped MJ during T. gondii
invasion, we previously failed to detect TgRON2 (GenBank
HQ110093) in the ring using two sera recognizing distinct regions
of the protein [5]. TgRON2 was only observed at a very early stage,
when the MJ appears as a dot at the apical contact with the host cell
and when parasites were treated with cytochalasin D (Cyt-D)
inducing a ‘‘static’’ junction that is not translocated to the posterior
end of the tachyzoites [5]. We hypothesized that TgRON2 is
engaged in intermolecular interactions precluding antibody bind-
ing.Inordertore-examinethefate ofTgRON2duringinvasion,we
generated new antisera directed against different domains of
TgRON2. Our previous antisera were produced against recombi-
nant proteins RON2n and RON2c (see Figure 1A), which we
rename here as TgRON2-1 and TgRON2-2, respectively.
TgRON2-1 is a His-tag recombinant protein that encompasses
thefirstputativeTMregion(TM1)andTgRON2-2 isa GST-fusion
protein corresponding to the peptide sequence located between the
next two putative TM regions (TM2 and TM3), including 14
residues of TM3. We produced two additional His-tag proteins and
specific sera. TgRON2-3 corresponds to the extreme C-terminal
part of the proteinafter TM3 and TgRON2-4 extends from the first
residue after the signal peptide to the residue preceding TM1. The
specificity of these sera was assessed by Western blot, and all
revealed a main proteinataround 150 kDa(Figure 1B), whichisthe
apparent size of RON2 in non reduced conditions [5]. Anti-RON2-
1 and anti-RON2-2 antibodies [5] are revealing additional bands
that could be unspecific degradation products or cross-reacting
proteins, as new antibodies generated against N- and C- terminal
parts confirm that there is no processing product visible in non-
reduced conditions (Figure 1B). Immunofluorescence assay (IFA),
revealed a perfect co-localisation with TgRON8 in the rhoptries of
intracellular parasites (Figure 1C). On invading parasites, we found
that both anti-RON2-3 and anti-RON2-4 antibodies recognized
exclusively the characteristic ring-shaped MJ (Figure 1D) and the
residual posterior dot that persists after invasion (Figure S1). This
definitively demonstrates that TgRON2 is present at the MJ during
the entire invasion process, as we previously hypothesized.
Anti-RON2-2 serum fails to co-immunoprecipitate
TgAMA1
We have previously shown that while NP40 lysis does not
disrupt the complex formed by the TgRONs and TgAMA1
(GenBank AF010264) [5], SDS lysis destabilizes it, although
allowing some TgAMA1-TgRON2 re-association after Triton-
X100 renaturation. This suggests a strong specific interaction
between these two partners (Figure 2A). We have now observed
that the anti-RON2-2 antibodies fail to immunoprecipitate the
complex (RON2 included) after NP40 lysis (data not shown). By
contrast anti-RON2-2 antibodies immunopurified TgRON2 after
SDS lysis, but this time failed to co-immunopurify TgAMA1
(Figure 2A), suggesting that only free TgRON2 was bound and
that the region corresponding to TgRON2-2 was not accessible to
these antibodies when linked to TgAMA1. Overall, these data
suggest that the region of TgRON2 that binds TgAMA1 is located
between amino acid 1295 and 1359 (Figure 1A). Interestingly,
TgRON2-2 is part of the C-terminal region of RON2, which is the
most conserved between apicomplexan RON2 orthologs (Figure
S2), suggesting a conserved function for this region.
The TgRON2-2 recombinant protein binds specifically to
TgAMA1
We developed a heterologous expression system that displays
TgAMA1 on the surface of BHK-21 mammalian cells with a type
1 TM topology, to investigate whether TgRON2-2 produced as a
GST-fused recombinant protein could interact specifically with
TgAMA1 in the absence of the other RON members of the MJ
complex. This topology mimics the one adopted by TgAMA1
once secreted onto the parasite surface [6], and allowed us to
Author Summary
Apicomplexa parasites are obligate intracellular pathogens
causing severe diseases such as the deadly malaria or
toxoplasmosis. Host cell invasion by these parasites
involves the formation of a structure between the apex
of the parasite and the host cell membrane called the
moving junction (MJ), which is built upon collaboration
between secretory organelles from the parasite that insert
microneme protein AMA1 in the parasite plasma mem-
brane and a complex of four rhoptry neck (RON2/4/5/8)
proteins at the host cell plasma membrane. We have now
identified a strong interaction between AMA1 and a C-
terminal region of RON2, which is crucial for invasion. In
spite of sequence variations in both proteins orthologs
from distinct Apicomplexa, we could show that this
interaction is functionally conserved and equally important
for the invasive process by Toxoplasma gondii and
Plasmodium falciparum. These findings open the way for
therapeutic approaches that could interfere with key
functions of parasitic MJ.
Apicomplexa Moving Junction RON2-AMA1 Interactions
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with TgRON2-2.
We thus constructed a plasmid encoding the TgMIC3 signal
sequence, previously shown to drive ectopic proteins in the
mammalian secretory pathway [24], directly fused to the mature
TgAMA1 coding sequence. Two potential N-glycosylation sites
(Asn-X-Ser/Thr) were mutated, since the native protein is not
glycosylated. The resulting pcDNA3-TgAMA1 plasmid was
transiently transfected in BHK-21 cells and expression of
TgAMA1 was analyzed by IFA. Using antibodies recognizing
either the cytoplasmic C-terminal tail of TgAMA1 (a-tail) or a
monoclonal antibody against the ectodomain (Mab B3.90, a-ecto)
on permeabilized cells, they labeled the whole cell together with a
perinuclear and vesicular pattern, suggesting that TgAMA1 was
present in the secretory pathway and exposed at the cell surface
(Figure 2B). Without permeabilization, only the a-ecto antibody
reacted, revealing TgAMA1 at the surface of transfected cells
(Figure 2B). The C-terminal part of AMA1 was thus not accessible
in these conditions, showing that TgAMA1 had adopted a type 1
TM insertion in BHK-21 plasma membrane, mimicking its native
topology at the parasite surface.
We then investigated whether recombinant TgRON2-2 would
bind BHK21 cells expressing TgAMA1 by incubating them with
the protein. Since TgRON2-2 is a GST-fusion protein, incubation
with GST alone was used as control. After several washes, the cells
were fixed, permeabilized and processed for IFA. Transfected cells
were detected using the TgAMA1 a-tail antibody, and binding of
TgRON2-2 or GST was analyzed with anti-GST. As a control,
BHK21 cells were transfected with a plasmid promoting surface
expression of TgMIC8 [24], another microneme protein expressed
at the parasite surface during invasion but absent from the MJ
complex [25]. While GST alone was never detected (Figure S3A),
TgRON2-2 was systematically and specifically detected at the
surface of TgAMA1-transfected cells (Figure 2C), but did not bind
to unrelated TgMIC8-expressing cells (Figure S3B), confirming a
specific interaction between TgRON2-2 and TgAMA1.
In order to verify if TgRON2-2 also bound native TgAMA1, we
tested the interaction by two other different approaches. In the
first (far western), tachyzoite proteins were separated by SDS-
PAGE, transferred to a nitrocellulose membrane, which was then
incubated with TgRON2-2 or GST and revealed using anti-GST
serum. As expected only TgRON2-2 bound to a protein band,
which co-migrated with TgAMA1 (Figure 2D). Moreover, we used
a conditional TgAMA1 knock-out T. gondii strain expressing an
anhydrotetracycline (Atc)-regulated exogenous copy (KOi AMA1)
[10], grown for 24h with Atc to turn down the expression of
TgAMA1. When lysates from these parasites were used,
TgRON2-2 was not found to bind anymore (Figure 2D),
Figure 1. TgRON2 is present at the MJ during the entire invasion process. (A) Overall scheme of TgRON2 with its signal peptide (SP, red) and
three predicted TM domains (TM, yellow). Bars indicate the region used to generate the antibodies (with amino acid positions numbered). (B) Western
blot analysis of T. gondii tachyzoite lysates (,5.10
6 parasites per lane) with the different immune sera against TgRON2. The arrow marks the full
length protein. (C) Co-localisation of TgRON2 with TgRON8 in the rhoptries of intracellular parasites, as revealed by the anti-RON2-3 and anti-RON2-4
antibodies. (D) Detection of TgRON2 at the MJ in invading parasites as revealed by the anti-RON2-3 and anti-RON2-4 antibodies.
doi:10.1371/journal.ppat.1001276.g001
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TgAMA1. Also, we analyzed TgRON2-2 binding to TgAMA1
in situ by incubating TgRON2-2 with extracellular parasites
expressing, or not, TgAMA1 at their surface, as, once secreted
from the micronemes, TgAMA1 relocalizes to the parasite surface.
TgRON2-2 was found to bind to the surface of TgAMA1-
expressing parasites, while it was undetectable in Atc-induced
parasites depleted from TgAMA1 (Figure 2E). GST, used as a
control, showed no binding (data not shown). Furthermore, we
assessed whether TgRON2-2 was able to specifically bind to the
micronemal pool of TgAMA1 present within the parasites. HFF
were infected with KOi AMA1 parasites [10] and grown without
or with Atc to express or turn down the expression of TgAMA1,
respectively. Both infected cell monolayers were fixed, permeabi-
lized and incubated with TgRON2-2 before revelation with anti-
GST. Remarkably, TgRON2-2 labeled the micronemes, co-
localizing perfectly with anti-AMA1 staining and this signal was
absent from TgAMA1-depleted parasites, while microneme
marker MIC3 was detectable in both conditions (Figure 2F).
The N-terminal domain of TgRON2 is exposed at the
cytosolic face of host cell membrane
We have previously shown that the MJ RON complex is
targeted to the host cell membrane during invasion, with RON4,
RON5 and RON8 being exposed on the cytosolic face of the
membrane, but we failed to determine the topology of RON2
Figure 2. Mapping the interactions between TgRON2 and TgAMA1. (A) Co-immunoprecipitation of TgAMA1 and TgRON2 after 0.6% SDS
lysis and Triton X100 renaturation of tachyzoite extract: anti-RON2-1 allows the recovery of both proteins, while anti-RON2-2 only recovers TgRON2.
(B) Transiently transfected BHK-21 cells express TgAMA1 at their surface in its native conformation, with the ectodomain exposed outside (revealed
with antibody B3.90, ‘‘ -ecto’’) and the cytosolic tail only detected after permeabilization (revealed with antibody CL22, ‘‘ -tail’’). (C) TgAMA1-
expressing BHK-21 cells were incubated with 0.1 mg/ml TgRON2-2 (a GST-fusion protein), washed and the binding of recombinant TgRON2 fragment
to TgAMA1-expressing cells was revealed with anti-GST antibody. Untransfected BHK-21 cell on the left showed no TgRON2 binding. (D) Far Western
blot analysis of TgRON2-2 binding to native TgAMA1. Extracts of tachyzoites expressing wild-type levels of AMA1 (WT) or depleted for this protein
(KOiAMA1+Atc) were separated by SDS-PAGE and transferred on a nitrocellulose membrane, which was incubated with GST alone or TgRON2-2 and
revealed with anti-GST. Incubation with TgRON2-2 revealed a band corresponding to the size of TgAMA1, as shown by specific antibodies and absent
from the AMA1-depleted cell line extracts, while anti-GST antibody did not react with tachyzoites. Anti-SAG1 was used as a loading control. (E)
TgRON2-2 binds specifically to surface-exposed TgAMA1. Fixed extracellular conditional KOi AMA1 tachyzoites induced (+Atc) to repress AMA1
expression, or non-induced (no Atc), were incubated with TgRON2-2, which was then revealed with anti-GST antibody. TgAMA1 was revealed with
anti-ectodomain B3.90 antibody. (F) TgRON2-2 binds specifically to TgAMA1 in micronemes. Fixed intracellular induced or non-induced conditional
KOi AMA1 tachyzoites were permeabilized and incubated with TgRON2-2, which labelled micronemes only when TgAMA1 was expressed. MIC3, an
unrelated microneme marker, was used as a control.
doi:10.1371/journal.ppat.1001276.g002
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TM predictions using bio-informatics tools (Table S1) modelled
TgRON2 as a TM protein bearing three TM domains (Figure 1A).
However, the exact number of these domains and the topology of
the protein at the plasma membrane could not be resolved. We
aligned the RON2 orthologs from different Apicomplexa species
to further refine a model of RON2 topology (Figure S2) using
several TM prediction programs to assess the conservation of the
TMs. The N-terminal region of RON2 is clearly quite variable.
TM1 is not conserved across all orthologs (Table S1) and displays
the lowest confidence index in predictions, suggesting that this
polypeptide sequence may not constitute a real TM domain.
Another hydrophobic amino acid-rich N-terminal region is quite
conserved among Apicomplexa RON2 orthologs (residues 404 to
424 in TgRON2) but does not yield a consistent TM prediction
(data not shown). By contrast, TM2 and TM3 are consistently
predicted in different Apicomplexa RON2 orthologs.
The fact that TgRON2-2 was able to bind TgAMA1 strongly
suggested that the segment between TM2 and TM3 was expressed
on the host cell surface. We thus tried to examine the topology of
TgRON2 by expression of the full length TgRON2 protein with
its own signal peptide in mammalian cells, using the pcDNA3.1
vector (Invitrogen). Attempts were also made with different
truncated RON2 versions, including each of the putative
transmembrane domains (TM1, amino acids 318–340; TM2,
amino acids 1277–1296; TM3, amino acids 1346–1368) preceded
by TgMIC3 signal peptide sequence [24]. In all cases, the
expressed proteins were detected in the endoplasmic reticulum of
transfected cells but were not trafficked to the plasma membrane,
which prevented us from using this heterologous system to study
TgRON2 topology. We therefore re-examined the topology of
TgRON2 by an approach we used previously [5] to localize
RON4, RON5 and RON8, using the newly generated anti-RON2
antibodies that allow detection of the protein at the MJ (Figure 1C).
To this end, we pre-loaded the host cells with anti-RON2-3 or
anti-RON2-4 antibodies using mechanical glass beads loading and
subsequently infected the cells with Toxoplasma tachyzoites. The
cells were then fixed during invasion, permeabilized and subjected
to fluorescent secondary antibody detection. As we have shown
before, RON4 is detected at the MJ in these conditions, as it is
exposed on the cytosolic face of the host cell and is thus accessible
to the antibodies, while RON2 could not be detected with the anti-
RON2-2 antibodies (Figure S4). However, by pre-loading host
cells with anti-RON2-4 we clearly detected TgRON2 at the
progressing MJ, or after completion of invasion (Figure 3), while
no signal was detected without permeabilization (data not shown).
Although some parasites displayed signals resembling the MJ, no
clear and consistent labelling was detected by preloading with anti-
RON2-3 (Figure S4), preventing us from determining whether this
part of the protein is exposed or not on the cytosolic side of the
membrane. This result demonstrated that at least the N-terminal
region of TgRON2 is exposed on the cytosolic side of the host cell
membrane, while TgRON2-2 most likely interacts with AMA1 on
the outside of host cell. In conclusion, even though we have not
clearly identified the TM domain(s) of RON2, our results show
that TgRON2 expressed segments on both sides of the host cell
membrane and that it is therefore an integral membrane
protein.
Figure 3. TgRON2 exposes at least one segment on the cytosolic side of the host cell plasma membrane. HFF cells were pre-loaded with
antibodies directed against TgRON2-4 and were pulse-infected for 2.5 min, followed by IFA. The upper images show a progressing invasion while the
lower images show a terminating invasion, in both cases the arrowhead indicates the MJ and magnifications are shown on the right. Scale bar=5mm.
doi:10.1371/journal.ppat.1001276.g003
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invasion through interaction with AMA1
Our previous study suggested a model of MJ organization where
the parasite exports sequentially a ligand (AMA1) at the parasite
cell surface and then its own receptor (RON2) at the host cell
membrane. Since recombinant TgRON2-2 interacts directly with
TgAMA1, we hypothesised that it competitively inhibits the
interaction between endogenous TgAMA1 and TgRON2 and
thus the invasion process. We therefore quantified the invasion
efficiency of T. gondii tachyzoites in HFF cells in the presence of
TgRON2-2 or GST. Extracellular parasites were pre-incubated
with recombinant proteins for 30 min before performing the
invasion of the host cells, still in the presence of recombinant
proteins. Recombinant TgRON2-2 inhibited the invasion by 69%
at 250 mg/ml compared to GST control (Figure 4A). If TgRON2-
2 indeed acts as a competitive inhibitor of the RON2-AMA1
interaction on the parasite/host cell interface, we reasoned that
the inhibitory effect would increase in a strain expressing less
AMA1. Accordingly, we took advantage of the T. gondii KOi
AMA1 strain described above that displays no invasion defect in
absence of Atc despite expressing only ,10% of the wild type
TgAMA1 level (Figure 4C) [10]. We therefore compared the
inhibitory effect of TgRON2-2 on KOi AMA1 with the wild type.
As shown in Figure 4B, incubation of KOi AMA1 parasites with
TgRON2-2 during the 30 minutes invasion time induced a
significantly more pronounced decrease in invasion efficacy
compared to wild-type. Similar results were obtained when the
invasion time was reduced to 5 minutes (Figure 4B).
The invasion process is a multistep mechanism starting with an
attachment step; we thus tested the ability of TgRON2-2 to inhibit
the attachment of tachyzoites on HFF cells fixed with glutaralde-
hyde, which blocks parasite penetration by rigidifying the target
cells. As shown in Figure S5, we did not observe any effect of
TgRON2-2 on attachment of KOi AMA1 or wild type strains.
Taken together, these results show that the inhibitory effect of
TgRON2-2 takes place through perturbation of the TgAMA1-
TgRON2 interaction, which is a critical step for the invasion
process occurring after the initial attachment step.
Figure 4. TgRON2-2 inhibits T. gondii invasion by interfering with endogenous RON2-AMA1 interaction. (A) Extracellular tachyzoites
were pre-incubated with either GST or TgRON2-2 at 125 mg/ml (3.75 mM) or 250 mg/ml (7.5 mM), before being added to confluent HFF monolayers for
30 min. Significant decrease in T. gondii invasion (t-test, ** p,0.01) was observed in the presence of TgRON2-2 at a concentration of 250 mg/ml. (B)
Decreasing TgAMA1 expression at the surface is correlated with an enhanced effect of TgRON2-2 on invasion. RH hxgprt- and KOi AMA1 strains were
compared for their invasion efficiency in the presence of GST or TgRON2-2 at 200 mg/ml (6 mM). The invasion process was stopped by cell fixation
after 30 min or 5 min. In both cases, KOi AMA1 shows a more pronounced invasion defect in presence of TgRON2-2 compared to RH hxgprt- (t-test,
*p ,0.05). Values represent means 6 standard deviations (SD), n=3, from a representative experiment out of 4 independent assays. (C) Western blot
analysis of TgAMA1 expression levels in RH strain (1) or in the KOi AMA1 strain grown in absence of Atc (2). Anti-ROP1 antibody was used as a loading
control.
doi:10.1371/journal.ppat.1001276.g004
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are evolutionarily conserved
Major components of the MJ are conserved between most
Apicomplexa species and are recovered as a complex by
immunopurification, suggesting a conserved function for the
complex. Conservation of the RON2-AMA1 interaction was
tested by expression of the region located between predicted TM2
and TM3 of P. falciparum 3D7 RON2 (GenBank AAN37108),
named PfRON2-5 (see Figure S2) and assay of its binding capacity
to P. falciparum 3D7 AMA1 (GenBank AAN35928) using the
mammalian expression system described above. Correct TM 1
topology of PfAMA1 at BHK-21 cells plasma membrane was first
verified by IFA performed with or without permeabilization
(Figure 5A). Indeed, the AMA1-fused C-terminal myc epitope was
only detected in permeabilized cells, while MAb F8.12.19, which
recognizes extracellular PfAMA1 domain III [26], gave a similar
staining with or without detergent treatment. Incubation of
PfAMA1-transfected cells with PfRON2-5 allowed detection of
PfRON2-5 binding to AMA1, but not of the GST control
(Figure 5B), thus demonstrating that RON2-AMA1 interaction is
conserved in Apicomplexa parasites.
AMA1 orthologs display the same folding pattern between
species but extensive polymorphism has been described [27].
Figure S2 shows that sequence polymorphism also occurs in the
region located between TM2 and TM3 of RON2 between
Apicomplexa genera. The possibility of conservation of the
RON2-AMA1 interaction between species was thereafter tested
by Enzyme-Linked Immuno-Sorbent Assay (ELISA). To this
end, we used recombinant AMA1 from T. gondii [20], P.
falciparum [28] and P. vivax (GenBank CAA76546) [29] coated
on ELISA plates and incubated them with increasing concen-
trations of TgRON2-2 or PfRON2-5. We observed a significant
b i n d i n go fP f R O N 2t oP f A M A 1( F i g u r e6 A )a n dT g R O N 2t o
TgAMA1 (Figure 6B), but no interspecies or intergeneric cross-
binding was seen. However, PfRON2-5 was able to bind both P.
falciparum 3D7-AMA1 and P. falciparum FVO-AMA1 (GenBank
CAC05390) (Figure 6C), indicating that the RON2 and AMA1
proteins have diverged between species but that the RON2-
Figure 5. RON2-AMA1 interaction is conserved in P. falciparum. (A) Pf3D7-AMA1 displays a type I TM topology at the plasma membrane of
BHK-21 cells. PfAMA1 transfected BHK-21 cells were subjected to IFA. Mouse MAb F8.12.19 recognizes extracellular PfAMA1 domain III that is
accessible with or without permeabilization, whereas anti-Myc antibody labels the intracellular C-terminal Myc tag in permeabilized cells only. (B)
PfAMA1 transfected BHK-21 cells were incubated with 20 mg/ml of GST or PfRON2-5. Recombinant proteins were detected using anti-GST antibody.
doi:10.1371/journal.ppat.1001276.g005
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conserved, and probably crucial, role of this interaction for the
invasion process.
A recent study showed that the AMA1-binding R1 peptide [30]
blocked invasion by preventing AMA1 interaction with the
PfRON complex [23] and that its binding region spanned the
full length of the AMA1 hydrophobic trough. Here, we
demonstrated that incubation with R1 prevents the binding of
PfRON2-5 to PfAMA1 in a dose-dependent fashion, while control
peptide P8 did not prevent this association (Figure 6D). As
expected, the competitive effect of R1 was restricted to P.
falciparum, as it was not able to inhibit the TgAMA1-TgRON2
interaction (data not shown). The competitive inhibitory effect of
R1 confirms the importance of the hydrophobic trough of AMA1
in the functional interaction with RON2 and as a target for
inhibitory molecules.
AMA1-binding R1 peptide inhibits host cell invasion by
Plasmodium merozoites and we have demonstrated that
TgRON2-2 displays a similar inhibitory effect on T. gondii
tachyzoites (Figure 4). Therefore, we next tested if PfRON2-5
could also prevent Plasmodium merozoites entry into red blood cells.
Highly synchronized P. falciparum 3D7 mature schizonts were
incubated either with R1 peptide as a positive control of invasion
inhibition, or PfRON2-5, or GST as a negative control. Equal
molar concentrations of recombinant proteins were used relative
to R1 peptide concentration. Blood smears were performed
16 hours post-invasion and counting of ring-stage parasites
allowed us to evaluate the invasion efficiency. As shown in
Figure 7, R1 peptide was able to decrease P. falciparum 3D7
invasion capacities to 37% at 10 mg/ml (4.3 mM) and to 11% at
50 mg/ml (21.7 mM), which is consistent with what has already
been reported [30]. Although addition of PfRON2-5 at low
concentration did not significantly affect merozoites re-invasion
compared to GST control, use of a higher concentration led to a
drastic inhibition of invasion, in the same range as with R1
peptide. In addition, we confirmed that the AMA1-RON2
interacting domains have evolved divergently, as PfRON2-5 was
not able to inhibit the invasion process of T. gondii parasites,
contrasting with the strong inhibitory effect observed with
TgRON2-2 or TgRON2-5 (Figure S6). TgRON2-5 is a shorter
construct corresponding exactly to the domain located between
TM2 and TM3, similar to the one produced for Plasmodium (Figure
S2), and that displays affinity to TgAMA1 (Figure S6). Overall,
this shows that, not only PfRON2-5 can bind to PfAMA1, but it
can also interfere with PfAMA1-PfRON2 interaction and block
Plasmodium invasion similarly to what we have observed for
Toxoplasma. Moreover, we have defined a similar minimal region
located between putative TM2 and TM3 both in P. falciparum and
T. gondii RON2, which is only able to interact specifically with
AMA1 from the same species.
Discussion
Host cell invasion, which is a critical process in T. gondii’s life
cycle, is highly dependent on the successive exocytosis of two
secretory organelles named micronemes and rhoptries, and the
formation of the MJ that anchors the parasite to the host cell
surface. The discovery of a rhoptry neck proteins complex
(RON2/4/5/8) localized at the MJ during invasion, and
association of this complex with the microneme protein AMA1,
strongly suggests the existence of a concerted action between
secreted parasitic proteins originating from microneme and
rhoptry organelles in the invasion step, and probably in the MJ
formation. However, the exact function and the interactions
Figure 6. Intra-species specificity of RON2-AMA1 interaction. ELISAs were carried out with increasing concentrations of Pf3D7-RON2-5 (A) or
TgRON2-2 (B) and recombinant AMA1 proteins from Pf3D7, PvSalI, TgRH, or PfFVO (C) strains coated at 1 mg/ml. GST alone was used as a control. (D)
Competitive ELISAs were performed using 20 mg/ml Pf3D7-RON2-5, 1 mg/ml Pf3D7-AMA1 and increasing concentrations of R1 peptide, or P8 control
peptide. Values represent means 6 SD, n=2, from a representative experiment out of 4 independent assays.
doi:10.1371/journal.ppat.1001276.g006
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largely unknown at present. Here, we have demonstrated that
there is a tight and specific interaction between rhoptry neck
protein RON2 and micronemal protein AMA1 in both Toxoplasma
and Plasmodium, and have shown that the interaction of these two
proteins at the parasite/host cell interface is essential for the
invasion process.
We have previously demonstrated a strong in vitro interaction
between native RON2 and AMA1 from Toxoplasma using
immunoprecipitation experiments [5]. In the present study, we
found that an antibody directed against a specific RON2 sequence
located between two putative C-terminal TM domains specifically
disrupts this interaction, suggesting that it competes with a zone of
interaction between the two proteins. When produced as a GST-
tagged recombinant protein, this domain showed significant
binding to recombinant AMA1 by ELISA. Moreover, TgRON2-
2 was able, in formaldehyde-fixed parasites, to bind specifically to
micronemes where AMA1 is located, or to the surface of
mammalian cells expressing AMA1 at their plasma membrane,
giving additional evidence of the interaction of this region of
RON2 with AMA1. More importantly, the use of recombinant
TgRON2-2 protein in invasion inhibition assays allowed us to
show the functional importance of the RON2-AMA1 interaction
during this process. Indeed, incubation of parasites with
TgRON2-2 inhibited invasion probably by competition with
native RON2 for AMA1 interaction. Consistent with this
conclusion, the inhibitory effect was more pronounced when a
mutant that weakly expresses AMA1 was used. These results show
for the first time that the RON2-AMA1 interaction is of significant
importance for the invasion process and that this interaction takes
place at the host-parasite interface once secreted from their
respective organelles, yet this AMA1 function does not seem to be
involved in the early attachment steps, as suggested before [10].
While previously we were only able to detect RON2 at the
nascent MJ [5], in the present study we have clearly demonstrated
the presence of RON2 at the progressing MJ in co-localisation
with other RON partners. RON2 is therefore present at the host
cell–parasite interface during the complete invasion process. In the
model we proposed for the MJ organisation, AMA1 is a TM
protein located on the parasite side, while RON2 (which has
several predicted TM domains), is its binding partner on the host
cell side after secretion by tachyzoites [5]. Using a comparative
analysis of TM segments in multiple apicomplexan RON2
orthologs with several prediction algorithms, we found that the
first predicted TM is not well conserved while the two TM
encompassing the AMA1-interacting fragment are generally
present. The use of a specific antiserum (anti-RON2-4) with
permeabilized host cells allowed us to unambiguously determine
that the N-terminal portion of RON2 was exposed inside,
although we were unable to definitively assign the location of
the C-terminus of the protein using the anti-RON2-3 antibody.
This antiserum, although relatively efficient at detecting TgRON2
by Western blot analysis (Figure 1B) and at the MJ by IFA after
fixation and permeabilization (Figure 1C), might be reacting
poorly in this assay if the C-terminal region of TgRON2 is
engaged in an interaction with an intracellular protein partner
during MJ formation that would preclude recognition by the
antibody in the particular conditions used for this assay (i.e.
antibody reacting directly on forming MJ structure in live parasites
entering host cell, fixation and permeabilization being performed
afterwards).
Overall, this has led us to precise RON2 topology at the host
cell plasma membrane, as we have now identified the region of
RON2 interacting with AMA1 (presumably exposed outside the
host cell) and another region localized inside the host cell
(Figure 8). However, the functionality of the last predicted TM
domain and the disposition of the well conserved C-terminal
domain are still under debate, as it could be either exposed inside,
or outside the host cell (Figure 8, A and B).
AMA1 is known to play a key role in invasion by Apicomplexa
parasites. For instance, it appears to be essential for Plasmodium
blood stage invasion, as no AMA1 knock-out mutants could be
obtained for this stage [11] and it is also essential for invasion by T.
gondii tachyzoites [10]. This micronemal protein, expressed at the
surface of the parasite, is a promising vaccine candidate for
malaria [13] and has hence been extensively studied in Plasmodium,
especially regarding binding regions of inhibitory antibodies. Some
antibodies bind regions of the P. falciparum AMA1 ectodomain that
are functionally important: for instance, MAb 4G2 has been
shown to block formation of a functional complex between
PfAMA1 and other components of the MJ, without identifying
precisely the AMA1-interacting protein [14]. The interaction
domain of PfAMA1 with other members of the complex seems to
be located within a particular hydrophobic groove located in the
ectodomain of PfAMA1. Similarly, inhibitory AMA1-binding
peptides that block P. falciparum merozoite invasion of the
erythrocyte have been described, such as peptide R1 [30], which
has been recently shown to bind the hydrophobic groove of
PfAMA1 and to prevent the association of this protein with other
MJ partners [23]. Here, we have also evaluated the intergeneric
conservation of the RON2-AMA1 interaction by performing
ELISA binding assays between recombinant PfAMA1 ectodomain
and recombinant PfRON2-5, similar to what we had demonstrat-
ed with their Toxoplasma counterparts. Although both proteins
display a significant degree of sequence variation between these
two Apicomplexa genera, the interaction was found to be strong
and specific (highlighted by the fact that the recombinant PfRON2
domain was binding strongly to PfAMA1, but not to recombinant
AMA1 from another Plasmodium species or from Toxoplasma).
Moreover, the role of this interaction for P. falciparum merozoites
and for T. gondii tachyzoites also appears to be similar, as in both
cases respective C-terminal RON2 recombinant proteins had a
blocking effect on host cell invasion. Thus, the RON2-AMA1
interaction is evolutionarily conserved, reflecting a co-evolution of
AMA1 protein with its RON2 interaction partner and underlining
its important functional role. Moreover, we show that the R1
peptide is a competitive inhibitor for the PfAMA1-PfRON2
Figure 7. PfRON2-5 inhibits invasion of red blood cells by
Plasmodium merozoites. Inhibition of invasion assays were per-
formed with 2% of mature schizonts parasites that were incubated with
10 mg/ml (4.3 mM) or 50 mg/ml (21 mM) of R1 peptide or molar
equivalent concentrations of PfRON2-5 or GST proteins. Parasitemia of
control infected red blood cells (IRBC) 16 hours post-invasion was used
as the 100% of invasion reference. R1 peptide inhibits parasites
invasion, and so does PfRON2-5 at the highest concentration compared
to GST control (t-test, * p,0.05). Values represent means 6 SD, n=4,
from a representative experiment out of 3 independent assays.
doi:10.1371/journal.ppat.1001276.g007
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trough and to block invasion after the initial attachment to the
erythrocyte and reorientation of the merozoite towards its apical
pole. We propose that the RON2 sequence located between the
two C-terminal TM domains could be structured as a loop (the
sequence contains two conserved cysteines that could be forming a
disulphide bridge) and interacts with AMA1 at the hydrophobic
groove that has been identified as important for interaction with
MJ partners in Plasmodium. Interestingly, the recent crystal
structure of TgAMA1 has revealed that this hydrophobic trough
is also conserved in Toxoplasma [20].
AMA1 is a leading malaria vaccine candidate, inducing
antibodies that inhibit invasion and confer protection in animals.
The sequence of AMA1 is rather conserved among various
Plasmodium spp., with the level of amino acid sequence identity
exceeding 50% in pairwise comparisons among all known
sequences. Strain variability in Plasmodium AMA1, however, is a
cause of concern for vaccinologists [13]. Indeed, the protective
response induced by AMA1 has been shown to be strain-specific
[28], largely as a consequence of the polymorphism of the regions
surrounding the hydrophobic trough [19] that binds to the RON
complex [14]. For example, the inhibitory effect of peptide R1 is
strain-specific, binding to PfAMA1 3D7 but not to its counterpart
from W2mef strain. By contrast, we have shown here that the
PfRON2-5 3D7 recombinant protein binds to PfAMA1 from
strains 3D7 and FVO, which suggests that the interaction is not
strain-dependent, although further studies will be necessary to
validate this apparent conservation. AMA1 and other MJ
components play an essential role in invasion by Apicomplexa
and for their virulence. Mapping the residues of AMA1 and
RON2 involved in the interaction and determining the confor-
mation they adopt upon interaction by co-crystallization and
structural determination should help designing small inhibitory
molecules targeting the conserved hydrophobic trough and
thereby minimize the risk of evasion by the parasite. This work
is a first step towards dissecting the specific interaction between
two members of the MJ protein complex but, more generally,
deciphering the MJ interactome will be important to define the
global molecular architecture of this structure. Anchoring of the
MJ on the host cell and links on the parasite side with the motor
complex are of particular interest to understand how such a
structure articulates and moves along the parasite during invasion.
Materials and Methods
Ethics statement
Thisstudy wasconducted accordingtoEuropeanUnionguidelines
forthehandlingoflaboratoryanimalsandtheimmunizationprotocol
for antibody production in rabbits was conducted at the CRBM
animal house (Montpellier) and approved by the Committee on the
Ethics of Animal Experiments (Languedoc-Roussillon, Montpellier)
(Permit Number: D34-172-4, delivered on 20/09/2009).
Host cells and parasite cultures
All T. gondii tachyzoites were grown in human foreskin fibroblasts
(HFF) or Vero cells grown in standard conditions. Tachyzoites of
the RH hxgprt- strain of T. gondii deleted for hypoxanthine guanine
phosphoribosyl transferase (DHX strain) [31] or KOi AMA1 [10]
were used throughout the study. P. falciparum 3D7 strain was
cultured in human red blood cells (EFS, Pyre ´ne ´es Me ´diterrane ´e,
France) at 5% hematocrit in medium composed of RMPI 1640
containing 25 mM HEPES, 10% human serum, and incubated at
37uC [32] in a tri-gas mix of 5% O2,5 %C O 2 and 90% N2.
Molecular cloning and production of recombinant
proteins
The primers used for constructions are listed in Table S2.
Plasmid pcDNA3-TgAMA1 was designed to express the
TgAMA1 protein in BHK-21 cells. It was constructed using
Figure 8. Current alternative models of the RON2-AMA1 interaction at the MJ. (A) with TgRON2 C-terminal domain exposed inside the host
cell; (B) with TgRON2 C-terminal domain exposed outside. TgAMA1 ectodomain was rendered from structural data ([20], (PDB ID: 2X2Z)) using Yasara
view software (www.yasara.org) with molecular surface rendering. Amino acids from the hydrophobic groove region are coloured in red. No structure
currently exists for TgRON2, but the protein was grossly schematized based on secondary structure predictions.
doi:10.1371/journal.ppat.1001276.g008
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ation sites (Asn at position 86 and 421 in AMA1 sequence) were
replaced respectively by two alanine residues using two steps of site
directed mutagenesis. We used a natural NheI site present at
position 193, after the cleavage site of the pro-peptide of TgAMA1
to clone the cDNA corresponding to the mature form of TgAMA1
(GenBank AF010264) in pcDNA3.1 The NheI/EcorI fragment of
pMAH14-AMA1 was cloned in pcDNA3.1 (Invitrogen) and next
the signal peptide from TgMIC3, PCR-amplified from pSS-MIC3
with primers ML5/ML6 [24], was inserted into the NheI site.
Compatible NheI and XbaI sites are present in ML5 and ML6,
respectively.
Plasmid pcDNA3-PfAMA1 was designed to express the
PfAMA1 protein in BHK-21 cells. Generation of a complete
synthetic variant gene of Pf3D7 AMA1 utilizing mouse codon
usage and lacking putative N-glycosylation sites as previously
described [17] was performed by Genscript, USA. Synthetic
Pf3D7-AMA1 gene was recovered from the pUC57 vector using
XbaI and HindIII restriction sites and subsequently cloned in the
mammalian expression vector pcDNA3.1/myc-His(A) (Invitro-
gen), thereby enabling an in frame C-terminal fusion of PfAMA1
with myc epitope.
Plasmid pGEX-TgRON2-2 was designed to express a N-
terminal GST-tagged recombinant protein TgRON2 corre-
sponding to the region between TM2 and TM3 and extending
into 14 residues of TM3 (V1295 to P1359) as described previously
[5].
Plasmid pGEX-TgRON2-5 was designed to express a N-
terminal GST-tagged recombinant protein TgRON2 correspond-
ing to the region between TM2 and TM3 (V1295 to P1347).
Corresponding TgRON2 fragment was obtained by PCR from
TgRON2 cDNA with primers ML224 and ML473.
Plasmid pET24a-TgRON2-3 was designed to express a
TgRON2 domain corresponding to the last 111 residues of the
protein and pET24a-TgRON2-4 was designed to express a
TgRON2 domain corresponding to residues 25 (starting after
predicted signal peptide sequence) to 288. The corresponding
DNA sequences were PCR-amplified from T. gondii TgRON2
cDNA (GenBank HQ110093) using primers ML333/ML334 and
ML398/ML399, respectively, and cloned between NdeI and XhoI
in pET24a (Merck Biosciences) allowing expression of C-terminal
His-tagged recombinant proteins.
Plasmid pET22b-TgAMA1 was designed to express the full
ectodomain (domains I, II, and III) for antibody production.
Primers ML390 and ML391 were used on T. gondii tachyzoite
cDNA to produce by PCR a fragment that was subsequently
cloned into pET22b with NdeI and XhoI restriction enzymes.
Soluble recombinant TgAMA1 for binding assays was produced as
described previously [20].
Plasmid pGEX-PfRON2-5 was designed to express a Pf3D7-
RON2 domain corresponding to the region between TM2 and
TM3 (M2020 to K2067). The corresponding DNA was PCR
amplified from P. falciparum genomic DNA using primers ML465
and ML495 and cloned between EcoRI and BamHI in pGex-4T-
3 (GE Healthcare Life Sciences), allowing expression of N-
terminal GST-tagged recombinant protein.
All the constructs, except pGEX-PfRON2-5, were transformed
into E. coli C41 cells to produce recombinant protein. Expression
of PfRON2-5 was done in BL21pRIG E. coli cells that contain
pRIG plasmid encoding 3 tRNAs (Arg, Ile and Gly) that recognize
codons abundant in P. falciparum genes and rarely used by E. coli.
His-tagged and GST-tagged proteins were purified by affinity
purification on nickel- or gluthatione-agarose column in native
(TgRON2-2, TgRON2-3, TgRON2-5 and PfRON2-5) or dena-
turing condition (TgAMA1, TgRON2-4) and according to the
manufacturer’s instructions. Recombinant proteins were used to
raise polyclonal antibodies in rabbit as described previously [5].
Before rabbit immunization, a further purification of TgRON2-4
was achieved by electroelution under denaturing conditions. For
binding assays, recombinant proteins were dialyzed against PBS
pH7, concentrated on Amicon Ultra 3K and quantified by Pierce
BCA protein assay.
Recombinant Plasmodium AMA1 ectodomains were produced in
Pichia pastoris as described previously for P. vivax [29], and P.
falciparum FVO and 3D7 [28]. Potential N-glycosylation sites were
removed by mutagenesis.
Cells transfection, glass beads loading of antibodies into
host cells and immunofluorescence
BHK-21 cells were transfected as previously described [24]. IFA
of invading parasites were obtained by synchronisation of invasion
at 4uC [3] or using a K
+ buffer shift [33]. For IFA of transfected
BHK-21 cells, intracellular parasites or invading parasites, cells
were fixed with 4% paraformaldehyde (PAF) in PBS for 30 min,
washed and permeabilized, or not, with 0.1% Triton X100 or with
0.05% saponin in PBS for 10 min, blocked with 10% fetal bovine
serum in PBS (PFBS) for 30 min, incubated with primary
antibodies diluted in 2% PFBS, washed and then incubated with
secondary antibody coupled to Alexa 594 or Alexa 488 (Sigma).
Finally the coverslips were washed and mounted onto microscope
slides using Immumount (Calbiochem). Images were collected
either i) with a Leica DMRA2 microscope equipped for
epifluorescence, the images being recorded with a COOLSNAP
CCD camera (Photometrics) driven by the Metaview software
(Universal Imaging Co.) or ii) with a Zeiss Axioimager epifluor-
escence microscope and images were recorded with a Zeiss
Axiocam MRm CCD camera driven by the Axiovision software
(Zeiss), at the Montpellier RIO imaging facility. The antibodies
used and their dilution were the following: mouse monoclonal
antibodies (MAb) anti-TgAMA1 CL22 (1:1000, anti-cytosolic
domain) [7] and B3.90 (1:300, anti-ectodomain) [6], mouse MAb
anti-RON4 T54H1 undiluted hybridoma culture supernatant
[34], rabbit anti-TgAMA1 (1:1000, anti-ectodomain, this work),
rat anti-RON2-2 (anti-RON2c, 1:1000) [5], rabbit anti-RON2-1
(anti-RON2n, 1:1000) [5], rat anti-RON8 (1:500) [5], rabbit anti-
RON2-3 (1:200) (this work), rabbit anti-RON2-4 (1:1000) (this
work), rabbit anti-MIC3 (1:1000) [35], rabbit anti-MIC8 (1:500)
[36], mouse MAb anti-P. vivax AMA1 F8.12.19 at 1 mg/ml [26],
commercial mouse MAb anti-cMyc 9E10 (1:400) or rabbit anti-
cMyc (A-14) antibodies (Santa Cruz Biotechnology) and rat anti-
GST antibodies (1:300).
Rabbit anti-RON2-1 (anti-RON2n) [5], rat anti-RON2-2
(anti-RON2c) [5] and rabbit anti-RON2-3 (this work) were
further affinity-purified on an antigen strip excised from a
nitrocellulose protein blot. Briefly, ,500 mg of respective purified
recombinant proteins were separated by SDS-PAGE and
transferred onto nitocellulose blot. Proteins were labeled with
Ponceau red staining and the corresponding strip was excised.
Strips were saturated in PBS+1% BSA (w/v) for one hour. 250 ml
of immune sera were adsorbed on their respective recombinant
proteins for 2 hours. Following extensive washes in PBS, specific
antibodies were eluted in 1 ml of 100 mM glycine pH 2.5 buffer
and immediately neutralized with one-tenth volume of 1 M Tris-
HCl pH 8.8.
Loading of antibodies into host cells by the glass bead
permeabilization method was performed as described previously
[5].
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Co-immunoprecipitation. Parasite solubilization in 1%
NP40 or in 0.6% SDS and immunosorption procedures were
done as described previously using rat anti-RON2-2 or rabbit anti-
RON2-1 [3]. Elution from beads was performed during 5 min at
95uC with SDS-PAGE sample buffer and co-immunoprecipitation
of AMA1 was detected using MAb CL22.
Expression in BHK-21 cells. Overnight transfected cells
were washed in HBSS (Invitrogen) before addition of TgRON2-2
or PfRON2-5 diluted in HBSS at concentrations ranging from
0.1 mg/ml to 10 mg/ml, or 20 mg/ml, respectively, for 1 h. After
five washes in PBS to remove unbound protein, cells were fixed in
4% PAF and further processed for IFA as described above.
ELISA. 100 ml of recombinant AMA1 protein diluted in 1 M
sodium-carbonate buffer pH 9.6 was coated at 1 mg/ml in
Maxisorp 96 wells plates (Nunc) and incubated overnight at 4uC
with gentle agitation. Unbound protein was removed by washing
in PBS, 0.05% Tween 20. Saturation was performed in blocking
buffer (PBS, 1% bovine serum albumin, 0.02% sodium azide) for
1 h. 100 ml of recombinant RON2 protein diluted in blocking
buffer was added to each well, and incubated 1 h with shaking.
Bound RON2 protein was detected using rat anti-GST (1:1000)
followed by an anti-rat IgG horseradish peroxidase conjugate
(1:2500) (ZyMAX, Invitrogen). Binding was visualized using
SIGMAFAST-OPD (o-phenylenediamine) tablet (Sigma Aldrich)
and absorbance read at 450 nm.
Competitive ELISA assays were essentially carried out as
described above, except that increasing concentrations of either
competitive P.falciparum R1 peptide [30] (VFAEFLPLFSKF-
GSRMHILK, PolyPeptide Laboratories, France) or T.gondii
control peptide P8 (SAPQAIAKATTS, Peptide 2.0, USA)
corresponding to a variable part of RON2-2, were pre-incubated
for 15 min with recombinant protein before being added to each
well.
Far western. T. gondii tachyzoites were lysed for 30 min at
37uC in a non-reducing SDS sample buffer and separated on 10%
polyacrylamide gel (,5.10
6 cells per lane). Proteins were
electrotransferred on nitrocellulose filters (Schleicher and
Schuell). Membranes were washed twice in PBS and incubated
for 2 hours at room temperature in PBS containing 1% bovine
serum albumin and 5% non-fat milk. Membranes were incubated
with GST or TgRON2-2 at 100 mg/ml in PBS for 2 h, washed 6
times in PBS for 10 min each and then probed as described
previously [3] with rat anti-GST (1:300), followed by goat anti-rat
IgG alkaline phosphatase conjugate (Promega). Mouse
monoclonal anti-SAG1 (T4 1E5) diluted 1:1000 was used as a
loading control [37].
In situ recombinant protein binding. Confluent HFF
monolayers grown on coverslips were infected with RH
tachyzoites for 18 h and fixed for 30 min in 4% PAF in PBS.
After permeabilization with 0.1% Triton X100 and saturation
with 10% PFBS for 30 min, the cells were incubated for one hour
with with 1 mg/ml of GST or TgRON2-2, washed and proceed as
described previously for IFA using anti-GST.
Invasion assays
T. gondii. Freshly released tachyzoites (1.10
6) were pre-
incubated 30 minutes at 37uC with 200 mg/ml (6 mM) of
recombinant RON2 proteins prior to addition onto confluent
HFFs grown in 16 wells Lab-Tek chamber slides (Nunc). Invasion
was allowed to take place during 30 minutes before extensive
washes in PBS buffer. 5 minutes synchronized invasions were
performed as described above at 4uC. IFA analysis was
subsequently performed as described previously.
P. falciparum. P. falciparum 3D7 parasites were sorbitol-
synchronyzed [38] prior to schizonts stage enrichment via the
magnetic method using MACS system (Miltenyi Biotec) [39].
100 ml of infected red blood cells (2% parasitemia, 0.75%
haematocrit) were mixed with 100 ml of R1 peptide or
recombinant protein diluted in RPMI 1640 supplemented with
human serum. R1 peptide concentrations were 10 mg/ml (4.3 mM)
and 50 mg/ml (21.7 mM) and equivalent molar concentrations of
PfRON2-5 and GST were used. Control blood smears were
performed at regular time points to check for proper merozoites
re-invasion. After 4–6 hours, most of the schizonts had ruptured
and free merozoites had already re-invaded. To facilitate counting,
blood smears were also collected 16 hours post-invasion and used
for ring-stage parasites counting.
Supporting Information
Figure S1 Co-localisation of TgRON2 with TgRON4 at the
residual junction (arrowhead) after completion of invasion.
Monoclonal T54H1 anti-RON4 antibody (green) and rabbit
polyclonal anti-RON2-3 and RON2-4 (red) antibodies were used.
Found at: doi:10.1371/journal.ppat.1001276.s001 (2.50 MB TIF)
Figure S2 Alignment of RON2 orthologues from different
Apicomplexan species (see Table S1 for database accession
numbers). Amino acid sequences were aligned using the MUSCLE
algorithm with Geneious software (www.geneious.com). Predicted
TM1, TM2 and TM3 (see Table S1) are annotated in red. Yellow
arrows on top of T. gondii and P. falciparum RON2 sequences
correspond to TgRON2-2 (long), TgRON2-5 (short) and
PfRON2-5 recombinant proteins, which are binding to AMA1.
Global sequence conservation is depicted under consensus
sequence with bars and colour scale (green: highly conserved,
red: less conserved). Background color for amino acids indicates
similarity, with a grayscale ranging from 100% similar (black) to
less than 60% similar (white).
Found at: doi:10.1371/journal.ppat.1001276.s002 (2.10 MB PDF)
Figure S3 Controls for specific binding of TgRON2-2 to Tg
AMA1. (A) GST does not bind to AMA1-expressing BHK-21
cells. BHK-21 cells were incubated with 10 mg/ml of GST.
TgAMA1 was revealed with anti-ectodomain B3.90 antibody.
TgRON2-2 binding is specific to the expression of TgAMA1 at the
surface of BHK-21 cells. (B) BHK-21 cells were transfected to
express unrelated TgMIC8 protein at their surface (revealed with
specific antibody) and they were incubated with of 10 mg/ml
TgRON2-2. In both cases cells were not permeabilized, to show
surface labeling, and anti-GST antibody was used for detection of
the recombinant proteins.
Found at: doi:10.1371/journal.ppat.1001276.s003 (4.13 MB TIF)
Figure S4 Use of glass bead cell antibody loading method to
assess the intracellular exposure of TgRON2 domains. HFF cells
were pre-loaded with antibodies directed against TgRON2-2 or
TgRON2-3 and were pulse-infected for 2.5 min, followed by IFA.
The upper series shows progressing invasions while the lower series
shows terminating invasions, in both cases the arrowhead indicates
the MJ and magnifications are shown on the right. Scale
bar=5 mm.
Found at: doi:10.1371/journal.ppat.1001276.s004 (9.48 MB TIF)
Figure S5 Incubation with TgRON2-2 does not prevent
attachment of T. gondii tachyzoites. Attachment of RHDhxgprt
(dark grey) or KOi AMA1 (light grey) strains to HFF cells fixed
with 0.075% glutaraldehyde, in presence of GST (plain bars) or
TgRON2-2 (dashed bars). Data presented here are the means
Apicomplexa Moving Junction RON2-AMA1 Interactions
PLoS Pathogens | www.plospathogens.org 12 February 2011 | Volume 7 | Issue 2 | e10012766SD, representative of five independent experiments done in
triplicate.
Found at: doi:10.1371/journal.ppat.1001276.s005 (1.16 MB TIF)
Figure S6 Plasmodium PfRON2-5 does not inhibit the invasion of
HFF cells by T. gondii. (A) Schematic representation of the
corresponding RON2 recombinant proteins used. (B) TgRON2-5
can bind efficiently to TgAMA1. ELISAs were carried out with
increasing concentrations of Pf3D7-RON2-5 (purple), TgRON2-2
(green), TgRON2-5 (red) or GST (black) on recombinant
TgAMA1 protein coated at 1 mg/ml. (C) Extracellular KOi
AMA1 tachyzoites were pre-incubated with either GST, PfRON2-
5, TgRON2-2 or TgRON2-5 at 200 mg/ml (6 mM), before being
added to confluent HFF monolayers for 30 min. Significant
decrease in T.gondii invasion (t-test, ** p,0.01) was specifically
observed in the presence of TgRON2-2 and TgRON2-5.
Found at: doi:10.1371/journal.ppat.1001276.s006 (0.74 MB TIF)
Table S1 Prediction of the conservation of three transmembrane
domains (TM1, TM2, TM3, see Figure S2) in apicomplexan
RON2 orthologues using different software: TMHMM (http://
www.cbs.dtu.dk/services/TMHMM/), TOP PRED (http://
mobyle.pasteur.fr/cgi-bin/portal.py?form=toppred), SOSUI (http://
bp.nuap.nagoya-u.ac.jp/sosui/sosui_submit.html), HMMTOP (http://
www.enzim.hu/hmmtop/) and CONPRED II (http://bioinfo.si.
hirosaki-u.ac.jp/,ConPred2/).
Found at: doi:10.1371/journal.ppat.1001276.s007 (0.03 MB XLS)
Table S2 Primers used in this study. Restriction sites used for
cloning are underlined.
Found at: doi:10.1371/journal.ppat.1001276.s008 (0.03 MB XLS)
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